Medicare Updated Articles Display Page

JF LOB Updated Artcles
Article ID Modified By Modified On Title
30281509 Kirby Schwartzbauer 2026-08-03 17:47:23.115 MLN Connects Special Edition: 3 Final Payment Rules - August 3, 2026
30281521 Kirby Schwartzbauer 2026-08-03 17:47:25.7 MLN Connects Special Edition: 3 Final Payment Rules - August 3, 2026
30281915 Kirby Schwartzbauer 2026-08-04 19:54:41.471 ICD-10 Diagnosis Coding Specificity Requirements
30284352 James Marko 2026-08-06 12:37:18.313 Billing and Coding: Electrocardiograms (A57326) - R12 - Effective October 1, 2023
30281443 Kirby Schwartzbauer 2026-08-03 15:44:17.301 Clinical Diagnostic Laboratories: Act Now Before Reporting Period Ends
30284587 James Marko 2026-08-06 13:32:08.199 Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R36 - Effective August 6, 2026
30281903 Kirby Schwartzbauer 2026-08-04 19:54:38.127 ICD-10 Diagnosis Coding Specificity Requirements
30284604 James Marko 2026-08-06 13:32:14.555 Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R36 - Effective August 6, 2026
30284723 James Marko 2026-08-06 13:42:35.005 Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R12 - Effective August 6, 2026
30284335 James Marko 2026-08-06 12:37:12.459 Billing and Coding: Electrocardiograms (A57326) - R12 - Effective October 1, 2023
30284672 James Marko 2026-08-06 13:37:40.377 Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R19 - Effective April 6, 2026
30284740 James Marko 2026-08-06 13:42:40.46 Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R12 - Effective August 6, 2026
30281326 Kirby Schwartzbauer 2026-08-03 15:36:14.728 Clinical Diagnostic Laboratories: Act Now Before Reporting Period Ends
30284655 James Marko 2026-08-06 13:37:35.354 Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R19 - Effective April 6, 2026
JD LOB Updated Artcles
Article ID Modified By Modified On Title
30281473 Kirby Schwartzbauer 2026-08-03 17:47:15.692 MLN Connects Special Edition: 3 Final Payment Rules - August 3, 2026
JE LOB Updated Artcles
Article ID Modified By Modified On Title
30281302 Kirby Schwartzbauer 2026-08-03 15:36:42.107 Clinical Diagnostic Laboratories: Act Now Before Reporting Period Ends
30284689 James Marko 2026-08-06 13:42:22.782 Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R12 - Effective August 6, 2026
30281879 Kirby Schwartzbauer 2026-08-04 19:54:32.509 ICD-10 Diagnosis Coding Specificity Requirements
30281485 Kirby Schwartzbauer 2026-08-03 17:47:18.343 MLN Connects Special Edition: 3 Final Payment Rules - August 3, 2026
30284318 James Marko 2026-08-06 12:37:07.286 Billing and Coding: Electrocardiograms (A57326) - R12 - Effective October 1, 2023
30281891 Kirby Schwartzbauer 2026-08-04 19:54:35.049 ICD-10 Diagnosis Coding Specificity Requirements
30284570 James Marko 2026-08-06 13:32:02.156 Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R36 - Effective August 6, 2026
30284301 James Marko 2026-08-06 12:37:01.324 Billing and Coding: Electrocardiograms (A57326) - R12 - Effective October 1, 2023
30281497 Kirby Schwartzbauer 2026-08-03 17:47:21.031 MLN Connects Special Edition: 3 Final Payment Rules - August 3, 2026
30284706 James Marko 2026-08-06 13:42:29.234 Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R12 - Effective August 6, 2026
30281314 Kirby Schwartzbauer 2026-08-03 15:36:57.304 Clinical Diagnostic Laboratories: Act Now Before Reporting Period Ends
30284553 James Marko 2026-08-06 13:31:56.95 Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R36 - Effective August 6, 2026
30284638 James Marko 2026-08-06 13:37:29.547 Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R19 - Effective April 6, 2026
30284621 James Marko 2026-08-06 13:37:23.688 Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R19 - Effective April 6, 2026
JA LOB Updated Artcles
Article ID Modified By Modified On Title
30281461 Kirby Schwartzbauer 2026-08-03 17:47:11.535 MLN Connects Special Edition: 3 Final Payment Rules - August 3, 2026